This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $200,000
OPeN seCRET: Optimizing Pragmatic, Novel strategies for iCTs in CeREbral venous Thrombosis
CIHR · 2023 · Principal investigator
- $15,000
Understanding research priorities for Cerebral Venous Thrombosis
CIHR · 2022 · Co-investigator
- $191,250
SECRET: Study of rivaroxaban for CeREbral venous Thrombosis
CIHR · 2017 · Co-investigator
OPeN seCRET: Optimizing Pragmatic, Novel strategies for iCTs in CeREbral venous Thrombosis
Principal investigators: Field, Thalia S; Lindsay, Mary Patrice; Roberts, Sharon E; Saposnik, Gustavo
Keywords: Cerebral Venous Thrombosis; Comparative Effectiveness; Patient-Centered Outcomes
Understanding research priorities for Cerebral Venous Thrombosis
Principal investigators: Field, Thalia S; Roberts, Sharon E
Keywords: Cerebral Venous Thrombosis; People With Lived Experience; Priority-Setting Partnerships; Stakeholder Engagement
SECRET: Study of rivaroxaban for CeREbral venous Thrombosis
Principal investigators: Field, Thalia S
Keywords: Anticoagulation; Cerebral Venous Thrombosis; Cognition; Health Economics; Patient-Centered Outcomes; Prognosis; Rare Diseases
EmPOwER: Engaging Persons with cerebral venous thrombosis for meaningful Outcomes and peER support: A patient engagement initiative of the SECRET (Study of rivaroxaban for CeREbral venous Thrombosis) Trial
Principal investigators: Field, Thalia S; Nadeau, Janel O
Keywords: Cerebral Venous Thrombosis; Patient-Oriented Outcomes; Prognosis; Stroke; Thrombosis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.